Margareta Brännström1, Kurt Boman. 1. Strategic Research Program in Health Care Sciences (SFO-V), Bridging Research and Practice for Better Health at Karolinska Institutet and Umeå University, Department of Nursing, Umeå University, Umeå, Sweden. margareta.brannstrom@nurs.umu.se
Abstract
BACKGROUND: Guidelines have concluded that there is a great need for new models of integrated care, e.g., heart failure and palliative care, in order to facilitate equality of care for dying patients, regardless of diagnosis. We found no evidence in the literature concerning the advantages and effects of integrated heart failure and palliative advanced home care for patients with severe chronic heart failure. AIM: The primary aim is to study the effects of integrated Palliative advanced homecarRE and heart FailurE caRE (PREFER) on patients' symptom burden, quality of life, and activities of daily living (ADL) as compared to usual care. METHOD: Prospective, randomized study with an open-evaluation PROBE design. Optimally treated outpatients with chronic heart failure of varying aetiologies in New York Heart Association classes III-IV will be eligible to participate. CONCLUSION: The PREFER study is designed to investigate whether a new concept of managing patients with severe chronic heart failure by integrating palliative homecare and active heart failure treatment will reduce symptom burden, increase quality of life and ADL, and reduce the number of hospitalizations in patients with severe chronic heart failure.
BACKGROUND: Guidelines have concluded that there is a great need for new models of integrated care, e.g., heart failure and palliative care, in order to facilitate equality of care for dying patients, regardless of diagnosis. We found no evidence in the literature concerning the advantages and effects of integrated heart failure and palliative advanced home care for patients with severe chronic heart failure. AIM: The primary aim is to study the effects of integrated Palliative advanced homecarRE and heart FailurE caRE (PREFER) on patients' symptom burden, quality of life, and activities of daily living (ADL) as compared to usual care. METHOD: Prospective, randomized study with an open-evaluation PROBE design. Optimally treated outpatients with chronic heart failure of varying aetiologies in New York Heart Association classes III-IV will be eligible to participate. CONCLUSION: The PREFER study is designed to investigate whether a new concept of managing patients with severe chronic heart failure by integrating palliative homecare and active heart failure treatment will reduce symptom burden, increase quality of life and ADL, and reduce the number of hospitalizations in patients with severe chronic heart failure.
Entities:
Keywords:
Heart failure; integrated care; palliative care; randomized controlled study
Authors: Lorraine S Evangelista; Solomon Liao; Marjan Motie; Nathalie De Michelis; Jennifer Ballard-Hernandez; Dawn Lombardo Journal: J Palliat Med Date: 2013-12-04 Impact factor: 2.947
Authors: Yuchieh Kathryn Chang; Holland Kaplan; Yimin Geng; Li Mo; Jennifer Philip; Anna Collins; Larry A Allen; John A McClung; Martin A Denvir; David Hui Journal: Circ Heart Fail Date: 2020-09-09 Impact factor: 8.790
Authors: Marie Bakitas; Meredith Macmartin; Kenneth Trzepkowski; Alina Robert; Lisa Jackson; Jeremiah R Brown; James N Dionne-Odom; Alan Kono Journal: J Card Fail Date: 2013-03 Impact factor: 5.712